Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.76 USD | -5.40% | -5.42% | +138.25% |
03:13pm | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
May. 08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |